Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Buti

Showing results (1071-1080 of 1,095) with videos related to

Pageof 110
Sort By:
Hepatology International|June 5, 2023
Real-world treatment outcome with protease inhibitor direct-acting antiviral in advanced hepatitis C cirrhosis: a REAL-C studyYu Jun Wong, Sally Tran, Chung-Feng Huang, et al.
Cancer Immunology, Immunotherapy : CII|September 7, 2023
Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective studyOndřej Fiala, Sebastiano Buti, Hideki Takeshita, et al.
Cancer Immunology, Immunotherapy : CII|April 18, 2024
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 studyFrancesco Massari, Matteo Santoni, Hideki Takeshita, et al.
Hepatology Communications|October 23, 2023
Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplantGautam Mehta, Antonio Riva, Maria Pilar Ballester, et al.
Journal of Viral Hepatitis|April 10, 2014
Historical epidemiology of hepatitis C virus (HCV) in selected countriesP Bruggmann, T Berg, A L H Øvrehus, et al.
Journal of Viral Hepatitis|April 10, 2014
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigmH Razavi, I Waked, C Sarrazin, et al.
Journal of Viral Hepatitis|April 10, 2014
Strategies to manage hepatitis C virus (HCV) disease burdenH Wedemeyer, A S Duberg, M Buti, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 22, 2026
Long-Term Mortality Following Hepatitis C Cure in a Real-World Multinational CohortFanpu Ji, Sally Tran, Hidenori Toyoda, et al.
Transplantation Direct|May 1, 2025
Pediatric Liver and Kidney Transplant Recipients Demonstrate Greater Serological Response to SARS-CoV-2 Vaccination Than AdultsTobias Laue, Maria Pilar Ballester, Lily Meoli, et al.
Journal of Clinical and Translational Hepatology|July 12, 2024
Real-world Effectiveness and Tolerability of Interferon-free Direct-acting Antiviral for 15,849 Patients with Chronic Hepatitis C: A Multinational Cohort StudyFanpu Ji, Sally Tran, Eiichi Ogawa, et al.
Pageof 110

Showing results (1071-1080 of 1,095) with videos related to

Sort By:
Pageof 110
Hepatology International|June 5, 2023
Real-world treatment outcome with protease inhibitor direct-acting antiviral in advanced hepatitis C cirrhosis: a REAL-C studyYu Jun Wong, Sally Tran, Chung-Feng Huang, et al.
Cancer Immunology, Immunotherapy : CII|September 7, 2023
Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective studyOndřej Fiala, Sebastiano Buti, Hideki Takeshita, et al.
Cancer Immunology, Immunotherapy : CII|April 18, 2024
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 studyFrancesco Massari, Matteo Santoni, Hideki Takeshita, et al.
Hepatology Communications|October 23, 2023
Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplantGautam Mehta, Antonio Riva, Maria Pilar Ballester, et al.
Journal of Viral Hepatitis|April 10, 2014
Historical epidemiology of hepatitis C virus (HCV) in selected countriesP Bruggmann, T Berg, A L H Øvrehus, et al.
Journal of Viral Hepatitis|April 10, 2014
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigmH Razavi, I Waked, C Sarrazin, et al.
Journal of Viral Hepatitis|April 10, 2014
Strategies to manage hepatitis C virus (HCV) disease burdenH Wedemeyer, A S Duberg, M Buti, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 22, 2026
Long-Term Mortality Following Hepatitis C Cure in a Real-World Multinational CohortFanpu Ji, Sally Tran, Hidenori Toyoda, et al.
Transplantation Direct|May 1, 2025
Pediatric Liver and Kidney Transplant Recipients Demonstrate Greater Serological Response to SARS-CoV-2 Vaccination Than AdultsTobias Laue, Maria Pilar Ballester, Lily Meoli, et al.
Journal of Clinical and Translational Hepatology|July 12, 2024
Real-world Effectiveness and Tolerability of Interferon-free Direct-acting Antiviral for 15,849 Patients with Chronic Hepatitis C: A Multinational Cohort StudyFanpu Ji, Sally Tran, Eiichi Ogawa, et al.
Pageof 110